Masato Fujisawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Masato Fujisawa has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Tomomoto Ishikawa
Division of Urology, Department of Organs Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
4 shared publicationsTomoaki Terakawa
3 shared publicationsGaku Kawabata
Kobe University Graduate School of Medicine
2 shared publications- Hideaki Miyake
Division of Urology Kobe University Graduate School of Medicine Hyogo Japan
2 shared publications Sadao Kamidono
Kobe University Graduate School of Medicine
2 shared publicationsA. Takenaka
Department of Urology, Kawasaki Medical School and Department of Urology, National Kobe Hospital, Kurashiki, Japan
1 shared publication
Latest Publications
- 20 May 2016
- p. 106-10
[Ligand-independent activation of androgen receptor].
- 1 June 2011
- p. 250-3
[The efficacy of PSA related parameters].
- 1 May 2004
- Published by Springer Nature in Urological Research
- Vol. 32 (2) , 104-106
Assessment of availability of magnetic resonance angiography (MRA) in renal arteriovenous fistula
We report two cases of cirsoid-type renal arteriovenous fistula (RAVF) which were difficult to differentiate from renal pelvic tumor by intravenous pyelogram (IVP) and computed tomography (CT) scan. Two women visited our department complaining of sudden asymptomatic macroscopic hematuria. CT scans showed an irregular mass in the right kidney. Magnetic resonance angiography (MRA) revealed a cirsoid-type RAVF. These patients were treated with transarterial embolization (TAE) using ethanol, geratin sponge, and a coil. It is suggested that MRA is useful for the diagnosis of renal arteriovenous fistula.
- 1 May 2004
- Published by Springer Nature in Urological Research
- Vol. 32 (2) , 104-106
Assessment of availability of magnetic resonance angiography (MRA) in renal arteriovenous fistula
We report two cases of cirsoid-type renal arteriovenous fistula (RAVF) which were difficult to differentiate from renal pelvic tumor by intravenous pyelogram (IVP) and computed tomography (CT) scan. Two women visited our department complaining of sudden asymptomatic macroscopic hematuria. CT scans showed an irregular mass in the right kidney. Magnetic resonance angiography (MRA) revealed a cirsoid-type RAVF. These patients were treated with transarterial embolization (TAE) using ethanol, geratin sponge, and a coil. It is suggested that MRA is useful for the diagnosis of renal arteriovenous fistula.
- 1 February 2004
- Published by Springer Nature in Urological Research
- Vol. 32 (1) , 49-50
Solitary fibrous tumor in the pelvic space
A case of a solitary fibrous tumor (SFT) of the pelvic space in a 64-year-old man is reported herein. Computed tomography (CT) of the pelvis showed a large mass enhanced heterogeneously left paracentral and posterior to the bladder and intimately associated with prostate. The site of origin of the mass could not be defined on CT because margins blended with the bladder, prostate, and rectum. A tumorectomy was performed and has remained well with no evidence of recurrence during the last 3 months. The tumor was 12.5×9.5×8.3 cm in size, solid with a fibromuscular capsule, and gray-tan in color. Histologically, the neoplasms were well circumscribed and composed of short spindle cells arranged without an obvious pattern. Immunohistochemically, these cells were strongly positive for CD 34 and negative for S-100, alpha SMA, and AE1/AE3.
- 1 February 2004
- Published by Springer Nature in Urological Research
- Vol. 32 (1) , 49-50
Solitary fibrous tumor in the pelvic space
A case of a solitary fibrous tumor (SFT) of the pelvic space in a 64-year-old man is reported herein. Computed tomography (CT) of the pelvis showed a large mass enhanced heterogeneously left paracentral and posterior to the bladder and intimately associated with prostate. The site of origin of the mass could not be defined on CT because margins blended with the bladder, prostate, and rectum. A tumorectomy was performed and has remained well with no evidence of recurrence during the last 3 months. The tumor was 12.5×9.5×8.3 cm in size, solid with a fibromuscular capsule, and gray-tan in color. Histologically, the neoplasms were well circumscribed and composed of short spindle cells arranged without an obvious pattern. Immunohistochemically, these cells were strongly positive for CD 34 and negative for S-100, alpha SMA, and AE1/AE3.
- Open Access
- 1 January 2004
- Published by Taylor & Francis in Archives of Andrology
- Vol. 50 (5) , 339-345
DIFFERENTIAL REGULATION OF INHIBIN SUBUNITS BY GERM CELLS IN HUMAN TESTES
Inhibin B is comprised of two dissimilar disulfide-linked subunits, termed alpha and betaB, and is physiologically more important than inhibin A in the male. The aim of this study was to investigate testicular expression of inhibin subtypes in infertile men to uncover any interaction between Sertoli cells and germ cells. Ten azoospermic patients with Sertoli cell only syndrome (SCO) and 39 oligozoospermic men were included in this study. Follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone concentrations were determined by chemiluminescence assays. The serum concentrations of inhibin B were measured by enzyme-linked immunosorbent assay. Immunohistochemical staining for the alpha-subunit, betaA-subunit, and betaB-subunit of inhibin were performed on testicular biopsy specimens. The results were that serum inhibin B was undetectable in azoospermic men with SCO, while it was 133.8 +/- 82.0 pg/ml in oligozoospermic men. There was little expression of betaA in the testes of any patient. Expression of inhibin alpha and betaB was observed in Sertoli cells. The percentage of Sertoli cells expressing inhibin alpha was similar in azoospermic patients with SCO (55.3% +/- 20.6%) and in oligozoospermic patients (42.8% +/- 30.4%). In contrast, expression of betaB in Sertoli cells of azoospermic patients (24.9% +/- 16.8%) was lower than in oligozoospermic men (43.4% +/- 25.5%: P = 0.0308). There are no significant correlations between testicular expression of inhibin betaB and the serum inhibin B concentrations. The expression of inhibin betaB by Sertoli cells is dependent on the coexistence of spermatogenic activity within these seminiferous tubules, explaining why the level of inhibin B is low in patients with SCO.
- 1 January 2004
- Published by Taylor & Francis in Archives of Andrology
- Vol. 50 (5) , 339-345
Open AccessDIFFERENTIAL REGULATION OF INHIBIN SUBUNITS BY GERM CELLS IN HUMAN TESTES
Inhibin B is comprised of two dissimilar disulfide-linked subunits, termed alpha and betaB, and is physiologically more important than inhibin A in the male. The aim of this study was to investigate testicular expression of inhibin subtypes in infertile men to uncover any interaction between Sertoli cells and germ cells. Ten azoospermic patients with Sertoli cell only syndrome (SCO) and 39 oligozoospermic men were included in this study. Follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone concentrations were determined by chemiluminescence assays. The serum concentrations of inhibin B were measured by enzyme-linked immunosorbent assay. Immunohistochemical staining for the alpha-subunit, betaA-subunit, and betaB-subunit of inhibin were performed on testicular biopsy specimens. The results were that serum inhibin B was undetectable in azoospermic men with SCO, while it was 133.8 +/- 82.0 pg/ml in oligozoospermic men. There was little expression of betaA in the testes of any patient. Expression of inhibin alpha and betaB was observed in Sertoli cells. The percentage of Sertoli cells expressing inhibin alpha was similar in azoospermic patients with SCO (55.3% +/- 20.6%) and in oligozoospermic patients (42.8% +/- 30.4%). In contrast, expression of betaB in Sertoli cells of azoospermic patients (24.9% +/- 16.8%) was lower than in oligozoospermic men (43.4% +/- 25.5%: P = 0.0308). There are no significant correlations between testicular expression of inhibin betaB and the serum inhibin B concentrations. The expression of inhibin betaB by Sertoli cells is dependent on the coexistence of spermatogenic activity within these seminiferous tubules, explaining why the level of inhibin B is low in patients with SCO.
- 1 January 2004
- Published by Taylor & Francis in Archives of Andrology
- Vol. 50 (6) , 443-448
VARICOCELE LIGATION ON FREE TESTOSTERONE LEVELS IN INFERTILE MEN WITH VARICOCELE
We have analyzed the effects of varicocele ligation on free testosterone levels, and investigated the interrelationships between free testosterone and fertility. The records were retrospectively evaluated for 42 infertile patients who underwent varicocele ligation, with serum free testosterone levels, follicle stimulating hormone (FSH), lutenizing hormone (LH), testosterone, estradiol, prolactin, ejaculated volume, sperm concentration and motility before and after surgery. Serum free testosterone levels increased from 12.97 ± 4.16 to 13.59 ± 3.93 pg/mL, but the difference was insignificant. The differences before and after surgery of patients in sperm concentration and motility were also insignificant. However, in free testosterone increasing group, the sperm concentration and motility increased significantly, from 4.05 ± 4.35 to 7.90 ± 8.19 million/mL (P = 0.01) and from 30.64 ± 21.87% to 41.00 ± 22.00%, respectively (P = 0.03). The increase in serum free testosterone level by varicocele ligation results in a significant improvement in sperm concentration and motility.
- 1 January 2004
- Published by Taylor & Francis in Archives of Andrology
- Vol. 50 (6) , 443-448
VARICOCELE LIGATION ON FREE TESTOSTERONE LEVELS IN INFERTILE MEN WITH VARICOCELE
We have analyzed the effects of varicocele ligation on free testosterone levels, and investigated the interrelationships between free testosterone and fertility. The records were retrospectively evaluated for 42 infertile patients who underwent varicocele ligation, with serum free testosterone levels, follicle stimulating hormone (FSH), lutenizing hormone (LH), testosterone, estradiol, prolactin, ejaculated volume, sperm concentration and motility before and after surgery. Serum free testosterone levels increased from 12.97 ± 4.16 to 13.59 ± 3.93 pg/mL, but the difference was insignificant. The differences before and after surgery of patients in sperm concentration and motility were also insignificant. However, in free testosterone increasing group, the sperm concentration and motility increased significantly, from 4.05 ± 4.35 to 7.90 ± 8.19 million/mL (P = 0.01) and from 30.64 ± 21.87% to 41.00 ± 22.00%, respectively (P = 0.03). The increase in serum free testosterone level by varicocele ligation results in a significant improvement in sperm concentration and motility.
- 1 January 2004
- Published by Taylor & Francis in Archives of Andrology
- Vol. 50 (4) , 255-260
CLINICAL EFFICACY AND SAFETY OF SILDENAFIL IN ELDERLY PATIENTS WITH ERECTILE DYSFUNCTION
Erectile dysfunction (ED) is a common medical disorder affecting elderly men. Sildenafil citrate has been shown to be an effective and well-tolerated oral agent for treating ED in the general population of adult men with ED of broad-spectrum etiology. Elderly men are more likely to have concomitant medical problems than the general population of men with ED. In this study, we examined the efficacy and safety of sildenafil administration in elderly patients with ED. Forty-four elderly men with ED (> or = 60 years old) of broad-spectrum etiology were treated with 25 mg or 50 mg doses of sildenafil citrate. Age ranged from 60 to 78 years (65 +/- 4.5; means +/- S.D.). Mean follow-up period was 12.3 +/- 6.5 months, with a range of 1 to 25 months. Primary efficacy assessments were performed using the International Index of Erectile Function 5 (IIEF5) before their first dose of sildenafil and after at least 4 weeks of therapy. Serum testosterone was measured before treatment. The mean IIEF5 among all patients increased from 8.5 +/- 3.9 to 20 +/- 4.2 after sildenafil use (P < 0.0001). In patients younger than 70 years, the IIEF5 score increased from 9.5 +/- 5.0 to 17 +/- 4.3 while in patients 70 years and older, the score increased from 8.2 +/- 3.6 to 21 +/- 3.9, a near normalization. The rate of improvement in younger men was higher than in older men. Serum testosterone before treatment was similar in the two groups. The most commonly experienced adverse events were flushing and dyspepsia, which occurred in 6.8% and 2.3%, respectively. No patients discontinued sildenafil treatment due to adverse events. In conclusion, oral sildenafil is efficacious and well tolerated by elderly men with ED, even among those older than 70 years.
- 1 January 2004
- Published by Taylor & Francis in Archives of Andrology
- Vol. 50 (4) , 255-260
CLINICAL EFFICACY AND SAFETY OF SILDENAFIL IN ELDERLY PATIENTS WITH ERECTILE DYSFUNCTION
Erectile dysfunction (ED) is a common medical disorder affecting elderly men. Sildenafil citrate has been shown to be an effective and well-tolerated oral agent for treating ED in the general population of adult men with ED of broad-spectrum etiology. Elderly men are more likely to have concomitant medical problems than the general population of men with ED. In this study, we examined the efficacy and safety of sildenafil administration in elderly patients with ED. Forty-four elderly men with ED (> or = 60 years old) of broad-spectrum etiology were treated with 25 mg or 50 mg doses of sildenafil citrate. Age ranged from 60 to 78 years (65 +/- 4.5; means +/- S.D.). Mean follow-up period was 12.3 +/- 6.5 months, with a range of 1 to 25 months. Primary efficacy assessments were performed using the International Index of Erectile Function 5 (IIEF5) before their first dose of sildenafil and after at least 4 weeks of therapy. Serum testosterone was measured before treatment. The mean IIEF5 among all patients increased from 8.5 +/- 3.9 to 20 +/- 4.2 after sildenafil use (P < 0.0001). In patients younger than 70 years, the IIEF5 score increased from 9.5 +/- 5.0 to 17 +/- 4.3 while in patients 70 years and older, the score increased from 8.2 +/- 3.6 to 21 +/- 3.9, a near normalization. The rate of improvement in younger men was higher than in older men. Serum testosterone before treatment was similar in the two groups. The most commonly experienced adverse events were flushing and dyspepsia, which occurred in 6.8% and 2.3%, respectively. No patients discontinued sildenafil treatment due to adverse events. In conclusion, oral sildenafil is efficacious and well tolerated by elderly men with ED, even among those older than 70 years.
- 1 December 2003
- Published by Springer Nature in Urological Research
- Vol. 31 (6) , 407-409
The efficacy of bilateral varicocelectomy in patients with palpable bilateral varicoceles: comparative study with unilateral varicocele
To determine whether the beneficial effect of bilateral varicocelectomy for bilateral varicoceles is similar to that of unilateral varicocelectomy for unilateral varicoceles, we compared the effect of varicocelectomy in men with unilateral and bilateral palpable varicoceles. Seventy-five men with unilateral varicocele and 34 with bilateral varicoceles were included in this study. Serum concentrations of follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone, prolactin, and estradiol were measured in morning blood specimens. Unilateral varicocelectomy was performed for unilateral and bilateral varicocelectomy for bilateral varicoceles using a microsurgical technique. The seminogram was determined every 3 months for up to 18 months. There were no significant differences in the change in the sperm concentration between the unilateral and bilateral groups. Sperm concentration before surgery in unilateral and bilateral group was 8.0±5.0×106/ml and 8.1±4.9×106/ml, respectively. Eighteen months after surgery, the sperm concentration significantly increased to 23.4±15.8×106/ml and 26.9±24.6×106/ml in unilateral and bilateral group, respectively. Preoperative motility in the unilateral and bilateral group was 38.9±15.2% and 39.6±15.7%, respectively. Eighteen months after operation, sperm motility had increased and was similar in the two groups, 43.1±19.2% and 45.4±17.6%. Sperm morphology was unaffected by surgery in either group. Improvement in the seminogram of patients following bilateral varicocelectomy was comparable to that in patients with unilateral varicocelectomy. Bilateral repair for bilateral varicocelectomies is justified for patients who desire improved spermatogenesis.
- 1 December 2003
- Published by Springer Nature in Urological Research
- Vol. 31 (6) , 407-409
The efficacy of bilateral varicocelectomy in patients with palpable bilateral varicoceles: comparative study with unilateral varicocele
To determine whether the beneficial effect of bilateral varicocelectomy for bilateral varicoceles is similar to that of unilateral varicocelectomy for unilateral varicoceles, we compared the effect of varicocelectomy in men with unilateral and bilateral palpable varicoceles. Seventy-five men with unilateral varicocele and 34 with bilateral varicoceles were included in this study. Serum concentrations of follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone, prolactin, and estradiol were measured in morning blood specimens. Unilateral varicocelectomy was performed for unilateral and bilateral varicocelectomy for bilateral varicoceles using a microsurgical technique. The seminogram was determined every 3 months for up to 18 months. There were no significant differences in the change in the sperm concentration between the unilateral and bilateral groups. Sperm concentration before surgery in unilateral and bilateral group was 8.0±5.0×106/ml and 8.1±4.9×106/ml, respectively. Eighteen months after surgery, the sperm concentration significantly increased to 23.4±15.8×106/ml and 26.9±24.6×106/ml in unilateral and bilateral group, respectively. Preoperative motility in the unilateral and bilateral group was 38.9±15.2% and 39.6±15.7%, respectively. Eighteen months after operation, sperm motility had increased and was similar in the two groups, 43.1±19.2% and 45.4±17.6%. Sperm morphology was unaffected by surgery in either group. Improvement in the seminogram of patients following bilateral varicocelectomy was comparable to that in patients with unilateral varicocelectomy. Bilateral repair for bilateral varicocelectomies is justified for patients who desire improved spermatogenesis.
- 1 December 2003
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 170 (6) , 2363-2365
Soluble Forms of Fas and Fas Ligand Concentrations in the Seminal Plasma of Infertile Men With Varicocele
Purpose: The Fas system in the testis has been identified as a key physiological regulator of apoptosis, an ongoing physiological process that limits the size of the germ cell population so...
- 1 December 2003
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 170 (6) , 2363-2365
Soluble Forms of Fas and Fas Ligand Concentrations in the Seminal Plasma of Infertile Men With Varicocele
Purpose: The Fas system in the testis has been identified as a key physiological regulator of apoptosis, an ongoing physiological process that limits the size of the germ cell population so...